Published in J Gerontol A Biol Sci Med Sci on October 24, 2013
Geroscience: linking aging to chronic disease. Cell (2014) 2.13
Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis (2014) 1.28
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort. AIDS (2014) 0.91
Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature. Am J Geriatr Psychiatry (2015) 0.90
HIV life cycle, innate immunity and autophagy in the central nervous system. Curr Opin HIV AIDS (2014) 0.87
Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci (2015) 0.83
Patient-centered care for people living with multimorbidity. Curr Opin HIV AIDS (2014) 0.82
Cardiovascular disease risk in an aging HIV population: not just a question of biology. Curr Opin HIV AIDS (2014) 0.82
Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep (2015) 0.80
Cellular Senescence as the Causal Nexus of Aging. Front Genet (2016) 0.80
A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe. BMC Res Notes (2016) 0.79
Aging and HIV: an evolving understanding. Curr Opin HIV AIDS (2014) 0.79
Cytomegalovirus and HIV: A Dangerous Pas de Deux. J Infect Dis (2016) 0.79
The trajectory of the blood DNA methylome ageing rate is largely set before adulthood: evidence from two longitudinal studies. Age (Dordr) (2016) 0.79
The silent war of CMV in aging and HIV infection. Mech Ageing Dev (2015) 0.79
Increased brain-predicted aging in treated HIV disease. Neurology (2017) 0.77
Alive and well? Exploring disease by studying lifespan. Curr Opin Genet Dev (2014) 0.77
Accelerating aging research: how can we measure the rate of biologic aging? Exp Gerontol (2015) 0.76
Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count. J Neurovirol (2014) 0.76
Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study. Curr HIV/AIDS Rep (2016) 0.76
Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion. Aging (Albany NY) (2017) 0.75
Bouncing Back: Resilience and Mastery Among HIV-Positive Older Gay and Bisexual Men. Gerontologist (2017) 0.75
Enhancing physical function in HIV-infected older adults: A randomized controlled clinical trial. Health Psychol (2016) 0.75
Impact of Depression and Inflammation on the Progression of HIV Disease. J Clin Cell Immunol (2016) 0.75
Fate of microglia during HIV-1 infection: From activation to senescence? Glia (2016) 0.75
Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers. Int Arch Occup Environ Health (2016) 0.75
How to predict the risk of fracture in HIV? Curr Opin HIV AIDS (2016) 0.75
Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60. J Neurovirol (2015) 0.75
Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs. Curr HIV/AIDS Rep (2016) 0.75
Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions. Open Forum Infect Dis (2016) 0.75
Accelerated and accentuated neurocognitive aging in HIV infection. J Neurovirol (2017) 0.75
Objective impairments of gait and balance in adults living with HIV-1 infection: a systematic review and meta-analysis of observational studies. BMC Musculoskelet Disord (2017) 0.75
Decreased myoblast differentiation in chronic binge alcohol administered simian immunodeficiency virus-infected male macaques: role of decreased miR-206. Am J Physiol Regul Integr Comp Physiol (2017) 0.75
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls. PLoS One (2017) 0.75
Have You Talked about It: Advance Care Planning among African Americans Living with HIV in Baltimore. J Urban Health (2017) 0.75
The Aging Population with HIV Infection. Trans Am Clin Climatol Assoc (2017) 0.75
Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men. AIDS (2017) 0.75
Redefining Aging in HIV Infection Using Phenotypes. Curr HIV/AIDS Rep (2017) 0.75
Insurance status and mortality among patients with AIDS. HIV Med (2017) 0.75
Immunosenescence and hurdles in the clinical management of older HIV-patients. Virulence (2017) 0.75
Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment. Curr Infect Dis Rep (2017) 0.75
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med (2008) 13.72
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med (2004) 13.55
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet (2008) 12.35
Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis (1999) 9.81
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab (2007) 9.77
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis (2011) 7.41
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA (2006) 7.14
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03
Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis (2011) 4.79
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood (2008) 4.34
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis (2011) 4.31
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol (2002) 4.25
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (2009) 4.19
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS (2006) 2.98
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS (1996) 2.95
Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods (2009) 2.78
HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75
Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65
Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis (2011) 2.56
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? Clin Infect Dis (2012) 2.45
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
Accelerated immune senescence and HIV-1 infection. Exp Gerontol (2007) 2.41
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med (2009) 2.30
Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell (2009) 2.21
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem (2011) 2.11
Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer (2005) 2.09
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS (2008) 2.01
HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ (2010) 1.98
Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc (2002) 1.94
Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology (1992) 1.92
Biomarkers of aging. Exp Gerontol (1988) 1.90
Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol (1999) 1.87
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One (2010) 1.83
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis (2012) 1.83
Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS (2010) 1.83
Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr (2009) 1.78
Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol (2007) 1.73
T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis (2011) 1.64
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS (2012) 1.63
Early immune senescence in HIV disease. Curr HIV/AIDS Rep (2010) 1.58
HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS (2012) 1.55
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet (2001) 1.55
Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS (2004) 1.53
Immunosenescence and HIV. Curr Opin Immunol (2012) 1.51
Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS (2007) 1.49
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Analysis of telomerase processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol Cell (2001) 1.47
Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke (2010) 1.44
Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. Clin Infect Dis (2012) 1.40
Ageing with HIV in South Africa. AIDS (2011) 1.37
Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr (2012) 1.30
HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clin Infect Dis (2011) 1.28
The aging of the HIV epidemic. Curr HIV/AIDS Rep (2008) 1.27
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages. Antivir Ther (2007) 1.24
Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women. PLoS One (2013) 1.24
HIV and premature aging: A field still in its infancy. Ann Intern Med (2010) 1.23
A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc (2012) 1.22
Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing (2010) 1.22
Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy. Aging Cell (2012) 1.21
Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr (2012) 1.20
Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study. AIDS (2013) 1.20
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging. J Infect Dis (2013) 1.16
Emerging HIV epidemic among older adults in Nanning, China. AIDS Patient Care STDS (2012) 1.15
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res (2000) 1.10
Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses. Clin Infect Dis (2011) 1.10
The paradox of the immune response in HIV infection: when inflammation becomes harmful. Clin Chim Acta (2012) 1.04
Improving precision in investigating aging: why telomeres can cause problems. J Gerontol A Biol Sci Med Sci (2010) 1.03
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group. J Acquir Immune Defic Syndr (1989) 1.00
The role of the T cell in age-related inflammation. Age (Dordr) (2012) 1.00
Translational research in immune senescence: assessing the relevance of current models. Semin Immunol (2012) 1.00
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J (2013) 0.98
Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech Ageing Dev (2007) 0.98
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies. J Infect Dis (2012) 0.98
Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol (2013) 0.97
Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health (2012) 0.96
The eye as a model of ageing in translational research--molecular, epigenetic and clinical aspects. Ageing Res Rev (2012) 0.89
HIV and ageing: premature ageing or premature conclusions? Curr Opin Infect Dis (2012) 0.88
Cytomegalovirus and immunological aging: the real driver of HIV and heart disease? J Infect Dis (2012) 0.85
Biomarkers in HIV disease. Curr Opin HIV AIDS (2010) 0.84
Cellular aging and senescence characteristics of human T-lymphocytes. Biogerontology (2011) 0.82
Telomerase-inhibitory effects of the triphosphate derivatives of some biologically active nucleosides. Nucleic Acids Res Suppl (2001) 0.82
Arterial stiffness and carotid intima-media thickness in HIV infected patients. Med Ultrason (2011) 0.78